Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain continuous glucose monitoring (CGM) data from
individuals taking Welchol compared to placebo. The CGM data will determine the effect on
glucose control of adding Welchol to an anti-diabetic medication regimen.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
HealthPartners Institute
Collaborators:
Daiichi Sankyo Inc. Daiichi Sankyo, Inc. International Diabetes Center at Park Nicollet